Catalyst
Slingshot members are tracking this event:
Cytokinetics expect to complete target enrollment of 600 patients in VITALITY-ALS in the first half of 2016
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
CYTK | Community voting in process |
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 17, 2016
Occurred Source:
http://phx.corporate-ir.net/phoenix.zhtml?c=142156&p=irol-newsArticle&ID=2195892
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Vitality-als, Tirasemtiv, Als Disease, Amyotrophic Lateral Sclerosis, Slow Vital Capacity